Endotoxin detection in end-stage kidney disease

Jonathan Wong, Hassan Jeraj, Enric Vilar, Adie Viljoen, Kenneth Farrington

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Aims: Endotoxin detection assays are not validated for use in end-stage kidney disease (ESKD). We investigated the accuracy and precision of the kinetic turbidimetric Limulus amoebocyte lysate (LAL) assay to detect endotoxin in plasma from patients with ESKD. Optimisation of endotoxin recovery from plasma using the detergent Tween 80 was also explored. Methods: Plasma samples from 7 patients with ESKD and 7 healthy subjects were spiked with different concentrations of endotoxin. Repeated measurements for endotoxin at each level of spike were performed to assess the accuracy and precision of spike recovery. Endotoxin recovery in plasma samples diluted in Tween 80 and water was compared. Results: Mean endotoxin spike recovery was 111.6% and 125.2% in ESKD and healthy subjects, respectively. There was no statistical difference in spike recovery between ESKD and healthy plasma. Precision of the LAL assay in plasma spiked with low (0.05 EU/mL) and high (0.5 EU/mL) concentration of endotoxin spikes was 24.1% and 8.9%, respectively. The use of Tween 80 as a diluent for plasma significantly improved spike recovery in ESKD plasma (100.1% vs 70.4%, p
Original languageEnglish
Pages (from-to)73-78
Number of pages6
JournalJournal of Clinical Pathology
Volume68
Issue number1
Early online date6 Nov 2014
DOIs
Publication statusPublished - 1 Jan 2015

Fingerprint

Dive into the research topics of 'Endotoxin detection in end-stage kidney disease'. Together they form a unique fingerprint.

Cite this